Detection of high-risk HPV in head and neck squamous cell carcinomas: Comparison of chromogenic in situ hybridization and a reverse line blot method

Applied Immunohistochemistry and Molecular Morphology

Volumn 19, Issue 6, 2011, Pages 574-578

  Stevens, Todd M ^a   Caughron, Samuel K ^b   Dunn, S Terence ^c   Knezetic, Joseph ^a   Gatalica, Zoran ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b Yellowstone Pathology Institute Inc   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

chromogenic in situ hybridization; head and neck squamous cell carcinoma; human papillomavirus

Indexed keywords

FORMALDEHYDE; PARAFFIN;

ANALYTIC METHOD; ARTICLE; CANCER CELL; CHROMOGENIC IN SITU HYBRIDIZATION; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC TEST ACCURACY STUDY; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NUCLEAR LOCALIZATION SIGNAL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; REVERSE LINE BLOT METHOD; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; VIRUS DETECTION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CHROMOGENIC COMPOUNDS; DNA, VIRAL; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS; RISK; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VIRAL LOAD;

EID: 81755184361     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318215248a     Document Type: Article

References (29)

1. Shroyer KR, Greer RO Jr. Detection of human papillomavirus DNA by in situ DNA hybridization and polymerase chain reaction in premalignant and malignant oral lesions. Oral Surg Oral Med Oral Pathol. 1991;71:708-713.
2. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720. (Pubitemid 30365531)
3. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004;31:744-754. (Pubitemid 39602680)
4. Ringstrom E, Peters E, Hasegawa M, et al. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res. 2002;8:3187-3192. (Pubitemid 35155029)
5. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100:407-420. (Pubitemid 351480511)
6. Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14: 467-475. (Pubitemid 40270113)
7. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100:261-269. (Pubitemid 351480538)
8. Schwartz SR, Yueh B, McDougall JK, et al. Human papillomavirus infection and survival in oral squamous cell cancer: a populationbased study. Otolaryngol Head Neck Surg. 2001;125:1-9. (Pubitemid 33661083)
9. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24: 736-747. (Pubitemid 46622040)
10. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24:5630-5636. (Pubitemid 46631302)
11. Termine N, Panzarella V, Falaschini S, et al. HPV in oral squamous cell carcinoma versus head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol. 2008;19:1681-1690.
12. Ha PK, Pai SI, Westra WH, et al. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res. 2002;8:1203-1209. (Pubitemid 34517659)
13. Sisk J, Schweinfurth JM, Wang XT, et al. Presence of human papillomavirus DNA in tonsillectomy specimens. Laryngoscope. 2006;116:1372-1374. (Pubitemid 44181449)
14. Eike A, Buchwald C, Rolighed J, et al. Human papillomavirus (HPV) is rarely present in normal oral and nasal mucosa. Clin Otolaryngol. 1995;20:171-173.
15. Yu-Fong Chang J, Lin MC, Chiang CP. High-risk human papillomaviruses may have an important role in non-oral habits-associated oral squamous cell carcinomas in Taiwan. Am J Clin Pathol. 2003;120:909-916.
16. Chih-Hsueh Chen P, Pan CC, Kuo C, et al. Risk of oral nonmalignant lesions associated with human papillomavirus infection, betel quid chewing, and cigarette smoking in Taiwan: an integrated molecular and epidemiologic study. Arch Pathol Lab Med. 2006;130:57-61. (Pubitemid 43077236)
17. Maitland NJ, Cox MF, Lynas C, et al. Detection of human papillomavirus DNA in biopsies of human oral tissue. Br J Cancer. 1987;56:245-250. (Pubitemid 17158811)
18. Kansky AA, Seme K, Maver PJ, et al. Human papillomaviruses (HPV) in tissue specimens of oral squamous cell papillomas and normal oral mucosa. Anticancer Res. 2006;26:3197-3201. (Pubitemid 44161823)
19. Lawton G, Thomas S, Schonrock J, et al. Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection. J Oral Pathol Med. 1992;21:265-269.
20. Lee WT, Tubbs RR, Teker AM, et al. Use of in situ hybridization to detect human papillomavirus in head and neck squamous cell carcinoma patients without a history of alcohol or tobacco use. Arch Pathol Lab Med. 2008;132:1653-1656.
21. Psyrri A, Prezas L, Burtness B. Oropharyngeal cancer. Clin Adv Hematol Oncol. 2008;6:604-612.
22. Dunn ST, Allen RA, Wang S, et al. DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods. J Virol Methods. 2007;143:45-54. (Pubitemid 46802824)
23. El-Mofty SK, Zhang MQ, Davila RM. Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma. Head Neck Pathol. 2008;2: 163-168.
24. Hafkamp HC, Speel EJM, Haesevoets A, et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J. Cancer. 2003;107:394-400. (Pubitemid 37266459)
25. van Houten VMM, Snijders PJF, van den Brekel MWM, et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer. 2001;93:232-235. (Pubitemid 32574279)
26. McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck. 1998;20:250-265. (Pubitemid 28169738)
27. Capone RB, Pai SI, Koch WM, et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res. 2000;6:4171-4175.
28. Kingma DW, Allen RA, Caughron SK, et al. Comparison of molecular methods for detection of HPV in oral and oropharyngeal squamous cell carcinoma. Diagn Mol Pathol. 2010;19:218-223.
29. Chernock RD, El-Mofty SK, Thorstad WL, et al. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol. 2009;3:186-194.